Abstract. Ampelopsis sinica root (ASR) is a known hepatoprotective folk traditional Chinese medicine. The anti-hepatoma activity of ethyl acetate extract from A. sinica root (ASRE) in vitro and in vivo and its possible mechanism were explored. This study was designed to investigate cytotoxicity by MTT assay, induction of apoptosis via Hoechst 33258 staining, scanning electron microscopy and bivariate flow cytometric analysis (Annexin V-FITC/PI), inflammation and apoptosis related genes expression by RT-PCR and p53 protein expression by immunofluorescence assay in HepG2 cells. Then, the antitumor activity in vivo was detected by hepatoma H22 xenograft tumor in mice. The results showed that ASRE had powerful anti-hepatoma activity in vitro without obvious toxicity on normal cells and could induce HepG2 cell apoptosis. The mechanism may be associated with downregulation of inflammatory cytokines including cyclooxygenase-2, 5-lipoxygenase and FLAP, increase of the ratio of bax/bcl-2, activation caspase-3 and inhibition of survivin, and increased expression of p53 protein. Furthermore, the HPLC assay showed the main compounds of ASRE were gallic acid, catechin and gallic acid ethyl ester. In animal experiments, ASR ethanol extract decreased the tumor weights of hepatoma H22 tumor-bearing mice. Therefore, ASR may be a potential therapeutic agent in the treatment of hepatocellular carcinoma.
Introduction
Ampelopsis sinica (Miq.) W.T. Wang, belongs to the genus of Ampelopsis (Vitaceae family), the root of which has been used as folk traditional Chinese medicine for heat-clearing and detoxifying, antibacterial and antivirus, and trauma disease. In 1987, Yang et al documented that A. sinica root could significantly decrease elevated glutamic-pyruvic transaminase (GPT) level caused by carbon tetrachloride and galactosamine (1) . According to Japanese patent publication, A. sinica root contains an effective anti-hepatic fibrosis element. Studies worldwide indicate that the extracts of A. sinica root has significant effects on hepatoprotection, descending transaminase, anti-hepatitis B virus and suppressing free radical damage (2) (3) (4) (5) (6) . Thus, we speculated that A. sinica root has anti-hepatoma activity.
Our 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) pilot experiments showed that the ethyl acetate part of A. sinica root had the best antitumor activity compared to petroleum ether, n-butyl alcohol and water-soluble part. This experimental study was performed to investigate the suppression effects of the ethyl acetate extract of A. sinica root on growth of HepG2 cells and to clarify the possible mechanism of its anti-hepatoma activity.
Materials and methods
Plant material preparation and extraction. A. sinica root (ASR) was collected in August 2013 from Macheng in Hubei. It was authenticated by Professor Keli Chen and the voucher specimens were deposited in the herbarium of Hubei University of Chinese Medicine (Wuhan, China). The ethanol extract was prepared as previously described (2) . The total ethanol extract was extracted with ethyl acetate to obtain the A. sinica root ethyl acetate extract (ASRE) which was lyophilized and dissolved in dimethyl sulfoxide (DMSO) for use in the follow-up experiments. The purity of ASRE was ~1.5%.
Reagents and cell cultures. Acetonitrile (chromatographically pure) and formic acid (mass spectrum magnitude) were Dulbecco's modified Eagle's medium (DMEM), trypsin and penicillin/streptomycin were obtained from Gibco (Grand Island, NY, USA). Fetal bovine serum (FBS) was purc hased from HyClone (Logan, UT, USA). TRIzol, MTT and DMSO were from Sigma-Aldrich (St. Louis, MO, USA). All chemicals and reagents were of analytical reagent grade. HepG2, hepatocellular carcinoma (HCC); A549, lung carcinoma; PC3, prostate carcinoma; MCF7, breast carcinoma; MGC803, gastric carcinoma; and HL-7702, normal human liver cells were obtained from China Center for Type Culture Collection of Wuhan University (Wuhan, China). All the cells were routinely cultured in DMEM supplemented with 10% FBS and 1% streptomycin/penicillin at 37˚C in a humidified incubator with 5% CO 2 under saturating humidity. The cells were subcultured with 0.25% trypsin when they were 80% confluent. Then, the cells in exponential growth phase were collected for the following experiments.
UPLC-Q-TOF MS
E analysis. ACQUITY UPLC/Xevo G2-XS QTof system coupled with an ACQUITY UPLC HSS T3 (50 mm x 2.1 mm, 1.7 µm) was used for the component analysis of ASRE. The mobile phase was composed of solvent A (0.1% formic acid in water) and solvent B (acetonitrile). The optimized elution conditions were as follows: 0.00-1.50 min, 5-23% B; 1.50-4.00 min, 23% B; 4.00-7.00 min, 23-95% B. The column temperature was maintained at 45˚C. The flow rate was set at 500 µl/min. The injection volume was 2 µl.
Leucine enkephaline was used for the lock mass. Each sample was analyzed in ESI -mode. The scan range was from 50 to 2,000 m/z. Desolvation gas flow and cone gas flow were set at 600 and 50 l•h -1 , respectively. The source temperature and the desolvation temperature were set at 100 and 450˚C, respectively. The capillary and cone voltage were set at 0.5 kV and 40 V, respectively. An alternation low-energy scan (off) and high-energy scan (collision energy ramped from 15 to 30 eV) were used to acquire the precursor (MS) and their fragments (MS E ) in ESI -mode. The instrument was controlled with MassLynx 4.1 software (Waters Corporation, Milford, MA, USA).
Cell viability assay. The in vitro antitumor activity of ASRE was assessed by MTT assay as described in detail elsewhere (7) on five different cancer cell lines. Briefly, the logarithmic growth phase cells were dispensed into a 96-well microplate at a density of 2x10 4 cells/ml and cultured at 37˚C in 5% CO 2 . Then the cells were exposed to ASRE at various concentrations ranging from 12.5 to 100 µg/ml for 72 h and the wells without ASRE treatment were considered as control. After the exposure period, the cells were cultured for an additional 4 h with 0.5 mg/ml MTT to product formazan. Then, 100 µl DMSO was added to each well to dissolve the formed formazan crystals. An automated microplate reader was used to determine the optical density at a wavelength of 490 nm. Relative cell growth inhibition rate (%) = (1 -OD treated /OD control ) x 100% (8). Cytotoxicity was evaluated by IC 50 (50% inhibition of viability) which was obtained from a regression analysis of dose-response curves. Assays were done with 3 parallel wells on three independent trials.
Inverted microscope observation. HepG2 cells were seeded into 24-well plates and cultured overnight, followed by exposed to different doses of ASRE (0, 50, 75 and 100 µg/ml). The morphological changes and growth status were observed and photographed using inverted light microscopy (IX73; Olympus, Tokyo, Japan).
Hoechst 33258 staining test. Hoechst 33258 staining was used to observe the morphology of apoptotic cells, as previously described (9) . The 1×10 5 cells/ml exponentially growing HepG2 cells were seeded in 6-well plates and incubated for 24 h. After the cells treated with various concentrations of ASRE (0, 50, 75 and 100 µg/ml) for 24 h, the cells were fixed with 70% ethanol for 20 min at room temperature. Then, after being washed with phosphate-buffered saline (PBS), the cells in each well were stained with 0.5 ml Hoechst 33258 solution at room temperature for 5 min. The cells were photographed under a inverted fluorescence microscopy (IX73; Olympus) at x400 magnification to observe morphological changes after being washed with PBS.
Scanning electron microscopy (SEM) observation. In order to accurately observe the details of morphologic changes of HepG2 cells treated with different concentrations of ASRE, the SEM observation was determined as previously described (10) with slight modifications. Briefly, HepG2 cells were cultured on sterile glass slides to cell slides. The slides of cells with or without ASRE were fixed with 2.5% glutaraldehyde overnight, and then fixed with 1% osmic acid for 4 h after several washes with PBS. The slides dehydrated in an ethanol series and dried with the lyophilizer. After gold sputtering, the slides were detected by a SEM (JSM-6501; JEOL Ltd., Tokyo, Japan). RT-PCR analysis. TRIzol was used to extract total cellular RNA from HepG2 cultured as above in the presence of ASRE for indicated time (0, 1.5, 3, 6, 9 and 12 h). Cells were grown without ASRE as control. RNA quantity and purity were assessed by UV spectrophotometer (TU-1901; Beijing Purkinje General Instrument Co., Ltd., Beijing, China) based on the absorbance measurement at 260 and 280 nm. Total RNA (1.5 µg) was quantitated and then was reverse transcribed with a Script RT kit (Tiangen Biotech Co., Ltd., Beijing, China) according to the manufacturer's instructions to synthesise complementary DNA (cDNA). The levels of cyclooxygenase-2 (COX-2), 5-lipoxygenase (5-LOX), FLAP, bax, bcl-2, caspase-3 and survivin mRNA expression were measured by RT-PCR using Tiangen SuperReal PreMix Plus (Tiangen Biotech Co., Ltd.) with specific primers (Table I ).
The actin gene was used as reference gene. The 20 µl reaction system contained 1 µl resulting cDNA template, 1 µl of specific sense primer, 1 µl of specific antisense primer and 10 µl 2X SYBR-Green SuperReal PreMix Plus, 7 µl RNasefree ddH 2 O. PCR amplification was initiated by 15 min of denaturation at 95˚C, and then followed by 40 cycles of 95˚C for 10 sec, 59-63˚C (annealing temperature) for 20 sec and 72˚C for 30 sec, and a final incubation at 72˚C for 5 min. All RT-PCR reactions for each sample were performed in duplicate. The obtained cycle threshold number of each gene (Ct value) was normalized into fold of relative changes according to the equation of 2 -ΔΔCT method (11) . The amplification products were analyzed on 1% agarose gel electrophoresis in 1X TAE buffer by ethidium bromide staining.
Immunofluorescent assay. HepG2 cells were cultured on sterile glass slides in 6-well plates. After 60% confluency, the cells were exposed to varying concentrations of ASRE (0, 50, 75 and 100 µg/ml) for 24 h. Cells were removed from the culture medium and washed 3 times with cold PBS. Then the cells in each well were fixed with 70% ice-cold ethanol in PBS at room temperature for 20 min. Triton X-100 (0.1%) in PBS was used to enhance the permeability of HepG2 cell membrane. The cells slides were blocked with 10% normal goat serum (Boster Biotechnology Co., Ltd., Wuhan, China) in the wet box for 1 h at room temperature after PBS washed 3 times for 5 min each. One hour later, the cells were washed gently with PBS and then incubated with the primary antibody, p53 antibody (FL-393; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) which is a rabbit polyclonal IgG, in the wet box at 4˚C overnight. After the primary antibody incubation steps, HepG2 cell slides were gently washed in PBS at least 3 times for 5 min each and then incubated with the FITC fluorescent-labeled goat anti-rabbit secondary antibody (Boster Biotechnology Co., Ltd.) in the wet box for 30 min at room temperature away from light. At the end of the immunofluorescent assay, the cells climbing should be always extensively washed with PBS, at least 3 times for 5 min each, and then should be dropped in antifade solution to avoid the attenuation of the FITC fluorescent. The samples were observed by an inverted fluorescence microscope (IX73; Olympus) at x200 magnification.
In vivo antitumor activity. Kunming mice (male, 20 ± 2 g) were procured from the Center of Experimental Animals in Wuhan University (Wuhan, China). The animal experimental protocol was approved by the Institutional Animal Care and Use Committee and the local experimental Ethics Committee (Laboratory Animal Certificate no. SYXK 2012-0068). The in vivo antitumor activity of ASR ethanol extract was further tested in hepatoma H22 tumor cell-bearing mouse model. Briefly, mice were injected with hepatoma H22 cells in the armpit respectively except the normal group mice. The recipient mice were randomly separated into five groups (each group 12 mice): a normal group, a negative control group, a positive control group and ASR ethanol extracts low-and high-dose groups. 5-Fu was given to the positive control group mice by intraperitoneal injection every other day. The negative control and normal groups were treated every day with normal saline only. The ASR ethanol extract low-and high-dose groups were administered with 1 and 5 g/kg ethanol extract by gavage every day separately. After 10 days of treatment, all mice were sacrificed, and the tumors, spleens and thymus were excised for weighing. Spleen and thymus index is the ratio of spleen and thymus weight (mg) to the body weight of the mouse (g).
Statistical analysis.
The experiments were performed at least 3 times. All values are presented as the means ± standard error of the mean (SEM). Variance of P-values obtained was calculated by means of a single-factor analysis of variance (ANOVA) test. Differences were considered to indicate a statistically significant result, at P-value <0.05.
Results

UPLC-Q-TOF MS
E assay. Fig. 1 shows the UPLC-Q-TOF MS base peak ion (BPI) chromatograms of ASRE in negative Cell viability assay. To evaluate the effect of ASRE on cell growth, the proliferation of five human tumor cell lines HepG2, PC3, MCF7, MG803, A549 and one normal cell HL-7702 were determined by MTT method. The IC 50 values which quantitatively expressed the potency of ASRE in inhibiting the cancer cells are shown in Table II , the ASRE exhibited highest antitumor activity against the HepG2 cell (IC 50 =32.9 µg/ml) compared to the other four tumor cells. In addition, for normal cell HL-7702 (normal human liver), ASRE had the lowest cytotoxicity compare to tumor cells. As shown in Fig. 2 , ASRE reduced tumor cell viability in a dose-dependent manner and the viability of HepG2 cells was significantly affected when the cells were treated with ASRE at the concentration of 25 µg/ml or above.
The ASRE at doses up to 200 µg/ml caused no more than 50% growth inhibition of the normal HL-7702 cells. The MTT results identified that the ASRE has antitumor activity on human tumor cells, especially HepG2 cell, and lower cytotoxicity on normal cells than against the cancer cells. Fig. 3 , marked morphological changes were observed as compared with untreated cells, while HepG2 cells were incubated with different doses of ASRE (25, 50 and 100 µg/ml) for 24 h. Untreated HepG2 cells attached closely on the culture in a homogeneous size with few floating cells and some of them contacted each other to form colonies (Fig. 3A) . However, ASRE treated cells made fewer cellular contacts and became round in shape with shrunken nuclei. It was observed that the adherent cells were reduced and the floating cells increased. Furthermore, these cell morphological changes were dosedependent (Fig. 3B-D) .
Morphological changes of HepG2 cells induced by ASRE under inverted microscope. As shown in
Hoechst 33258 staining. To analysis the effect of ASRE on the morphology of apoptotic cells, Hoechst 33258 staining test was conducted. After exposing to 100 µg/ml ASRE for 48 h, distinct morphological changes in chromatin morphology such as crenation, condensation and fragmentation were observed in HepG2 cells (Fig. 4) . SEM observation. The ultrastructural changes of HepG2 cells after respectively exposed to various concentrations (0, 50, 75 and 100 µg/ml) were observed under SEM. As shown in Fig. 5A -C, with the increase of the ASRE concentration, the treated cells became shrunken and displayed spheres, adherence was not good gradually, showed less or no microvilli, and formation of apoptotic bodies was observed (Fig. 5D ).
ASRE induces apoptosis in HepG2 cells in vitro.
To confirm whether ASRE induced cell death via apoptosis, the cells stained with Annexin V-FITC and PI were analyzed by flow cytometry. In the early stages of apoptosis, phosphatidylserine (PS) was everted from the internal layer to the outer face of the plasma membrane. Annexin V was functioned as a sensitive probe of apoptosis in early phase for its high affinity to PS on the cell membrane surface. ). In this study, we accept the Annexin V-FITC positively stained (early and late stage of apoptosis) cells as apoptotic population. As shown in Fig. 6 , the apoptosis population (%) of HepG2 cells increased from 5.96 to 52.46% when ASRE concentration increased from 0 to 100 µg/ml. Similarly, the apoptosis population (%) of HepG2 cells increased from 5.95 to 39.97% when the acting time of ASRE increased from 0 to 24 h (Fig. 7) . The results support time-and dose-dependent late apoptotic induction properties of ASRE on HepG2 cells.
Effect of ASRE on inflammation factors and apoptosis-related gene expression.
To further explore the potential mechanism of ASRE on inhibiting cell growth and inducing apoptosis, mRNA expression of several inflammation-related genes and apoptosis-related genes were investigated by RT-PCR assay. As shown in Fig. 8 , the level of COX-2, 5-LOX and FLAP mRNA was gradually decreased with the incubation time increasing from 0 up to 12 h, which implied ASRE may In another aspect, bax and bcl-2 are a pair of most valuable genes for research in bcl-2 family, and the ratio of bax/ bcl-2 determines whether a cell undergoes apoptosis. Caspase activation is known as a major step in apoptosis. Caspase-3 plays key role in the process of transmitting apoptosis signs, and survivin could be one of the most powerful anti-apoptosis factors discovered. Our data suggested that the mRNA expression of bax and caspase-3 were upregulated by ~1.48-and 2.33-fold, respectively, while bcl-2 and survivin were downregulated by ~66.14 and 71.5%, after treatment of ASRE Figure 5 . The SEM graphs of HepG2 cells after exposed to various concentrations of ASRE with x4,000 magnification. (A) 0 µg/ml; (B) 50 µg/ml; (C) 75 µg/ml; (D) 100 µg/ml. SEM, scanning electron microscopy; ASRE, ethyl acetate extract from Ampelopsis sinica root. for 12 h. In addition, the mRNA expression levels of bax, bcl-2, caspase-3 and survivin change regularly with the action time of ASRE extending to 12 h.
Immunofluorescence assay. To further clarify the involvement of apoptosis pathway induced by ASRE in HepG2 cells, expression of apoptosis-related protein p53 was measured by immunofluorence stain. Fig. 9 clearly illustrates that the fluorescence intensity increased with the increasing of ASRE concentration, which revealed ASRE treatment resulted in upregulation of the tumor suppressor protein p53 expression.
Antitumor activity in vivo. Due to the good antitumor activities in vitro of ASRE, we conducted animal research to evaluate the antitumor effect of ASR ethanol extract in vivo. As daily observation, no mouse died when treated with ASR ethanol extracts below the dosages of 5 g/kg/day. The effects of ASR ethanol extract on mice transplanted with hepatoma H22 are presented in Table III . The inhibitory rates were 27.00 and 59.14% at the dosages of 1, 5 g/kg/day, respectively. The results revealed that the higher dose ASR ethanol extracts (5 g/kg/day) significantly decreased the tumor weights of H22 tumor-bearing mice compared to the control group (P<0.01). Furthermore, ASR ethanol extracts did not decrease the spleen and thymus index of the tumor-bearing mice (Table III; Fig. 10 ).
Discussion
The majority of HCC cases arise in the setting of underlying liver disease, such as chronic hepatitis B or C which lead to inflammation-induced lesions in the liver, hepatic fat accumulation, progressive fibrosis and irreversible cirrhosis (16) (17) (18) . Studies worldwide have indicated that the extract of ASR has significant effect on hepatoprotection, descending transaminase, anti-hepatitis B virus, and suppressing free radical damage (2-6). Thus, we hypothesized that ASR had anti-hepatoma activity. The findings in this study showed that ASRE had dose-dependent antitumor activity against various tumor cells, especially on HepG2 cells (IC 50 =32.9 µg/ml), and was less harmful to HL-7702 cells (IC 50 >150 µg/ml) than the tested tumor cells, which indicated that ASRE inhibited proliferation of cancer cells selectively.
To date, several phytocompounds have been isolated from ASR, and both the pure compounds and crude extracts have displayed antioxidative effects and anti-inflammatory activities (2) . The ethyl acetate portion of ASR showed stronger antitumor activity in pre-test than other portions probably due to the principal polyhydroxylphenolic compounds, such as gallic acid and catechin. Previous studies have indicated that gallic acid (an important phytochemical in pomegranates) and catechin (the primary phytochemical in green tea) have cancer-preventing activities in a variety of cancer cell types (19) (20) (21) (22) , and their cancer-preventing activities have a certain relationship with their antioxidant and anti-inflammatory activities (23) (24) (25) (26) . According to our experiment and literature, ASRE was found to exhibit higher anti-hepatoma activity than both gallic acid (IC 50 =106.85 µg/ml) (27) and catechin which inhibited the growth of HepG2 cell lines at a concentration of 100-200 µg/ml (28) . Similar results were seen in co-treatment of catechin and caffeine which resulted in a greater degree of cell inhibition than catechin or caffeine alone (29) . Thus, further research on testing the effects of catechin and gallic acid in combination are needed.
The close association between cancer and chronic inflammation has been recognized for centuries. COX-2, 5-LOX and FLAP have been confirmed to be associated with occurrence, development and metastasis of several kinds of human tumors (30) (31) (32) . Research has shown that excessive expression of COX-2 which plays its carcinogenesis role by inhibiting apoptosis, promoting cell division and proliferation, accelerating angiogenesis and blocking cell cycle (33) (34) (35) is emerged in malignant tumors, such as human breast cancer, esophageal squamous cell carcinomas, prostate cancer and colon cancer (36) (37) (38) (39) . Several groups have shown that 5-LOX pathway plays an important role in tumor growth (40, 41) . As a 5-LOX activating protein, FLAP plays an important role in 5-LOX activity (42) . Based on the RT-PCR results, the level of COX-2, 5-LOX and FLAP mRNA was gradually decreased with the incubation time after ASRE treatment, it is likely that the inhibitory effect of ASRE on HepG2 cell is associated with its anti-inflammatory properties.
The process of apoptosis is complex, and it is well-known that there are two main apoptotic signaling pathways, the mitochondria-mediated pathway and the death receptor-mediated pathway. In mitochondrial-mediated apoptosis pathway, the bcl-2 family members such as pro-apoptotic member bax and anti-apoptotic member bcl-2 have been considered to be vital regulators and the ratio of bax/bcl-2 largely determines whether cells will experience apoptosis (43) (44) (45) . The mitochondria and the death receptor-mediated pathways converge to caspase-3, the activation of which means cells would undergo apoptosis unavoidably. p53 functions as a transcription factor regulating downstream genes important in cell cycle arrest, DNA repair, and apoptosis, loss of p53 in many cancers leads to apoptosis inhibition (46) . In our study, ASRE treatment resulted in an upregulation of bax and downregulation of bcl-2, increased the ratio of bax/bcl-2, activated caspase-3 and promoted p53 protein expression. Combined with the findings in our experimental study, it could be assumed that ASRE lead to apoptosis of cancer cells through inflammatory cytokines mediated pathway and mitochondria-mediated pathway. Increasing expression of p53 protein after ASRE treatment indicated the antitumor mechanisms of ASRE are also connected to the upregulation of p53 protein.
In conclusion, the present study demonstrated that ASRE has a powerful anticancer activity in vitro and in vivo without obvious toxicity. The mechanism of apoptosis induced by ASRE may be associated with downregulation of inflammatory cytokines including COX-2, 5-LOX and FLAP, the increase of the ratio of bax/bcl-2, activation of caspase-3 and inhibition of survivin, and the increasing expression of p53 protein, may provide experimental evidence for the possibility of ASRE being a potential therapeutic agent in the treatment and/or prevention of HCC.
